(Q35825329)

10 August 2017

Population pharmacokinetics of levosimendan in patients with congestive heart failure (English)

1 reference

10 August 2017

congestive heart failure

1 reference

1 reference

5

Mats O Karlsson

1 reference

10 August 2017

E Niclas Jonsson

1

1 reference

10 August 2017

Saila Antila

series ordinal

2

1 reference

10 August 2017

Lynn McFadyen

series ordinal

3

1 reference

10 August 2017

Lasse Lehtonen

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

55

1 reference

10 August 2017

6

1 reference

10 August 2017

544-551

1 reference

Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Myocardial efficiency during levosimendan infusion in congestive heart failure.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Automated analysis of levosimendan in human plasma by on-line dialysis and liquid chromatography

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Clinical pharmacokinetics in heart failure. An updated review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Prediction of creatinine clearance from serum creatinine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Assessment of actual significance levels for covariate effects in NONMEM.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Estimating population kinetics.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884248

Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01778.X

Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01778.X

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

21 January 2018

1 reference

12 December 2020

Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension

1 reference

12 December 2020

Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure

1 reference

12 December 2020

Studies on psychomotoric effects and pharmacokinetic interactions of the new calcium sensitizing drug levosimendan and ethanol

1 reference

12 December 2020

Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin

1 reference

12 December 2020

10.1046/J.1365-2125.2003.01778.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference